A time to stop prescribing antioxidant vitamins to prevent and treat heart disease?

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 8, 2001, Pages 1253-

  Kuller, Lewis H ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; APOLIPOPROTEIN A1; ASCORBIC ACID; BETA CAROTENE; HIGH DENSITY LIPOPROTEIN; SELENIUM; SIMVASTATIN;

CANCER PREVENTION; CARDIOVASCULAR DISEASE; CLINICAL RESEARCH; CLINICAL TRIAL; DRUG EFFECT; EDITORIAL; HUMAN; LIPOPROTEIN BLOOD LEVEL; OUTCOMES RESEARCH; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0035574716     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/atvb.21.8.1253     Document Type: Editorial

References (8)

1. Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL
2. Safety and tolerability of combined niacin plus simvastatin in CAD patients with low HDLc with or without diabetes
3. Is there a vitamin E paradox?
4. Design of Physicians' Health Study II: A randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials
5. Is there a potential therapeutic role for vitamin E or other antioxidants in atherosclerosis?
6. Commentary: Beyond beta-carotene: Antioxidants and cardiovascular disease
7. Vitamin E supplementation increases the resistance of both LDL and HDL to oxidation and increases cholesterol ester transfer activity
8. Prospective association between lipid soluble antioxidants and coronary heart disease in men: The multiple risk factor intervention trial